541 related articles for article (PubMed ID: 26944863)
21. Progestin intrauterine devices versus copper intrauterine devices for emergency contraception.
Ramanadhan S; Goldstuck N; Henderson JT; Che Y; Cleland K; Dodge LE; Edelman A
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013744. PubMed ID: 36847591
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
23. Interventions for emergency contraception.
Cheng L; Che Y; Gülmezoglu AM
Cochrane Database Syst Rev; 2012 Aug; (8):CD001324. PubMed ID: 22895920
[TBL] [Abstract][Full Text] [Related]
24. Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: Implications for backup contraception recommendations.
Fay KE; Clement AC; Gero A; Kaiser JE; Sanders JN; BakenRa AA; Turok DK
Contraception; 2021 Nov; 104(5):561-566. PubMed ID: 34166648
[TBL] [Abstract][Full Text] [Related]
25. Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
Spotnitz ME; Natarajan K; Ryan PB; Westhoff CL
Obstet Gynecol; 2020 Feb; 135(2):319-327. PubMed ID: 31923062
[TBL] [Abstract][Full Text] [Related]
26. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
[TBL] [Abstract][Full Text] [Related]
27. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
[TBL] [Abstract][Full Text] [Related]
28. Emergency contraception.
Dunn S; Guilbert É;
J Obstet Gynaecol Can; 2012 Sep; 34(9):870-878. PubMed ID: 22971457
[TBL] [Abstract][Full Text] [Related]
29. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
[TBL] [Abstract][Full Text] [Related]
30. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
Bilgehan F; Dilbaz B; Karadag B; Deveci CD
J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
[TBL] [Abstract][Full Text] [Related]
31. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
[TBL] [Abstract][Full Text] [Related]
32. Copper intrauterine device placement 6-14 days after unprotected sex.
Thompson I; Sanders JN; Schwarz EB; Boraas C; Turok DK
Contraception; 2019 Sep; 100(3):219-221. PubMed ID: 31176689
[TBL] [Abstract][Full Text] [Related]
33. Emergency contraception.
Gemzell-Danielsson K; Rabe T; Cheng L
Gynecol Endocrinol; 2013 Mar; 29 Suppl 1():1-14. PubMed ID: 23437846
[TBL] [Abstract][Full Text] [Related]
34. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.
Andersson K; Odlind V; Rybo G
Contraception; 1994 Jan; 49(1):56-72. PubMed ID: 8137626
[TBL] [Abstract][Full Text] [Related]
35. Use of ulipristal acetate and levonorgestrel for emergency contraception: a follow-up study.
Baird AS; Trussell J; Webb A
J Fam Plann Reprod Health Care; 2015 Apr; 41(2):116-21. PubMed ID: 24869461
[TBL] [Abstract][Full Text] [Related]
36. Emergency contraception: a review.
Corbelli J; Bimla Schwarz E
Minerva Ginecol; 2014 Dec; 66(6):551-64. PubMed ID: 25313947
[TBL] [Abstract][Full Text] [Related]
37. Intrauterine device continuation rates and reasons for discontinuation in a Central European clinic with a high standard of care and ultrasound follow-up: a retrospective cohort study.
Bachofner M; Blickenstorfer K; Hutmacher J; Wehrle L; Leeners B; Merki-Feld G
Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):407-414. PubMed ID: 30628516
[TBL] [Abstract][Full Text] [Related]
38. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
Xiao B; Zeng T; Wu S; Sun H; Xiao N
Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
[TBL] [Abstract][Full Text] [Related]
39. Emergency contraception: Oral and intrauterine options.
Black KI; Hussainy SY
Aust Fam Physician; 2017 Oct; 46(10):722-726. PubMed ID: 29036770
[TBL] [Abstract][Full Text] [Related]
40. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
